VivoSense Revenue and Competitors
Estimated Revenue & Valuation
- VivoSense's estimated annual revenue is currently $6.7M per year.
- VivoSense's estimated revenue per employee is $126,000
Employee Data
- VivoSense has 53 Employees.
- VivoSense grew their employee count by 39% last year.
VivoSense's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Chief Product Officer | Reveal Email/Phone |
2 | VP Business Development, Founding Team | Reveal Email/Phone |
3 | VP Business Development | Reveal Email/Phone |
4 | VP Algorithm Development | Reveal Email/Phone |
5 | Chief Technology Officer | Reveal Email/Phone |
6 | Chief Algorithm Officer at VivoSense | Reveal Email/Phone |
7 | Chief Science Officer | Reveal Email/Phone |
8 | Data Scientist | Reveal Email/Phone |
9 | Chief Product Officer | Reveal Email/Phone |
10 | Project Manager | Reveal Email/Phone |
VivoSense Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $43596.7M | 127104 | N/A | N/A | N/A |
What Is VivoSense?
VivoSense is the world leader in data analysis consulting and software, specializing in wearable sensor physiological monitoring solutions for clinical trials, healthcare research and consumer wellness. VivoSense develops regulatory compliant digital biomarkers using the data from wearable sensors. Digital biomarkers are used to accurately measure drug and treatment effect in patients in regulated clinical trials and healtcare research. VivoSense is the first analytics company to develop novel digital biomarkers from wearable sensor data, which constitute primary and secondary clinical endpoints in regulated international pharmaceutical trials. Several of these studies are in rare disease indication and have reached the open-label phase of development at top-ten pharma.
keywords:N/A
N/A
Total Funding
53
Number of Employees
$6.7M
Revenue (est)
39%
Employee Growth %
N/A
Valuation
N/A
Accelerator
VivoSense News
VivoSense is one of many tech startups operating in the clinical trial system space. The company Lightship raised $40 million last year to build...
VivoSense, Inc., is an agile end-to-end scientific solutions company developing novel digital endpoints from wearable sensor data. We are...
This strategic investment from the Debiopharm Innovation Fund and the Perceptive Xontogeny Venture (PXV) Fund will allow VivoSense to...